Eat that Fish

Most studies on prostate cancer prevention focus on the initial prevention of the cancer. Rarely do we see studies on preventing advanced prostate cancer. Now a study has shown that consuming omega-3 fatty acids appear to protect against developing advanced prostate cancer. In other words, eating a serving of fish each week could dramatically reduce [...]

Can Bone Pain Predict Survival in Men with Metastatic Hormone-Refractory Prostate Cancer Treated with Docetaxel? What are the Implications?

A small study of 145 men with asymptomatic metastatic hormone-refractory prostate cancer (HRPC) was conducted to determine the benefit of starting early chemotherapy with docetaxel. Collected data were analyzed from these subjects who were treated with chemotherapy between February 2000 and June 2002 in one French center. The men were categorized into three groups according [...]

Support Prostate Cancer Research Funding NOW

The Department of Defense manages a significant fund given by congress to finance high risk and high impact research. One of the specific diseases that is funded is prostate cancer. In my personal opinion this particular program has had a significant effect on our lives. Unfortunately, prostate cancer has continued to take a back seat [...]

A Request for Study Subjects

A graduate student, Patrica Ames, has requested that I announce her request for subjects to participate in a study she is performing about clinical trial participants. Here it is: Invitation: Hello. I am reposting this request for volunteers to help me with my PhD research. I am very grateful that some have already spent the [...]

Positive Results from a Phase I-II Trial of MDV3100, Perhaps a New Alternative Hormone Blockade Option

There has been some positive news coming out of the ASCO conference in Florida this past week. One of the most significant pieces of positive news deals with the results of a phase I-II trial of the drug known as MDV3100. Basically, more than half of subjects in the study with castration-resistant prostate cancer responded [...]

Go to Top